anmelden
FTSE All-Share
5.541,24
PKT
+61,46
PKT
+1,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.02.21 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 15.02.21 | Prudential buy | Deutsche Bank AG | |
| 15.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 12.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 12.02.21 | Shell (ex Royal Dutch Shell) overweight | JP Morgan Chase & Co. | |
| 12.02.21 | Shell (ex Royal Dutch Shell) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | Bernstein Research | |
| 12.02.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.02.21 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 12.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 12.02.21 | London Stock Exchange (LSE) Outperform | RBC Capital Markets | |
| 12.02.21 | Shell (ex Royal Dutch Shell) buy | Goldman Sachs Group Inc. | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 11.02.21 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 11.02.21 | Shell (ex Royal Dutch Shell) buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca overweight | Barclays Capital | |
| 11.02.21 | AstraZeneca Neutral | UBS AG | |
| 11.02.21 | Prudential buy | Jefferies & Company Inc. | |
| 11.02.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 11.02.21 | GSK buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 11.02.21 | Prudential overweight | Barclays Capital | |
| 10.02.21 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 10.02.21 | BAT Outperform | Credit Suisse Group | |
| 10.02.21 | GSK Sell | Deutsche Bank AG | |
| 10.02.21 | AstraZeneca buy | Deutsche Bank AG | |
| 09.02.21 | GSK Neutral | JP Morgan Chase & Co. | |
| 09.02.21 | HSBC Sector Perform | RBC Capital Markets | |
| 09.02.21 | GSK buy | Jefferies & Company Inc. | |
| 08.02.21 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Unilever buy | Jefferies & Company Inc. | |
| 08.02.21 | Unilever buy | Deutsche Bank AG | |
| 08.02.21 | Barclays Neutral | Goldman Sachs Group Inc. | |
| 08.02.21 | GSK Neutral | UBS AG | |
| 08.02.21 | AstraZeneca Neutral | UBS AG | |
| 08.02.21 | Unilever overweight | Barclays Capital | |
| 06.02.21 | Barclays buy | Jefferies & Company Inc. | |
| 05.02.21 | London Stock Exchange (LSE) Outperform | Credit Suisse Group |